NCT05672108View on ClinicalTrials.gov

Phase II Trial of Lung Chemoemobolization

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 12, 2023

Primary Completion Date

October 28, 2026

Study Completion Date

October 28, 2026

Conditions
Lung Non-Small Cell CarcinomaMediastinal NeoplasmPleural NeoplasmLung Metastases From Any PrimaryEndobronchial MetastasesColon CancerSarcoma
Interventions
PROCEDURE

Computed Tomography

Undergo CT

DRUG

Ethiodized Oil

Given IA

DRUG

Mitomycin

Given IA

PROCEDURE

Transarterial Chemoembolization

Undergo TACE

DEVICE

Tris-acryl Gelatin Microspheres

Given IA

Trial Locations (2)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

91010

RECRUITING

City of Hope Medical Center, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER